USA BioEnergy Secures Johnson Matthey, Honeywell Technologies For New SAF Plant

USA BioEnergy LLC has selected Johnson Matthey Plc and Honeywell International Inc. to provide process technologies for its Bon Wier, Texas bio-refinery, focused on producing synthetic paraffinic kerosene (SPK) and Sustainable Aviation Fuel (SAF). The facility will utilize forest thinnings as feedstock, employing Fischer-Tropsch pathway technologies from both firms, and is projected to convert one million tons of biomass annually into 65 million gallons of transportation fuels, marking a significant advancement in alternative fuel production.

Analysis

Johnson Matthey Plc (JMAT.L) and Honeywell International Inc. (HON) have secured a notable technology partnership with USA BioEnergy for its Bon Wier, Texas bio-refinery, a project focused on producing Sustainable Aviation Fuel (SAF). The selection validates their respective process technologies—JM's FT CANS and Honeywell's FT Unicracking—which utilize the Fischer-Tropsch pathway for converting biomass into high-value fuels. The facility's planned capacity to convert one million tons of forest thinnings into 65 million gallons of fuel annually represents a material application of their technologies. For investors, this partnership underscores JMAT's and HON's strategic positioning as key enablers in the energy transition, specifically within the hard-to-abate aviation sector, and highlights a tangible commercial win that aligns with growing demand for renewable fuels and ESG-centric solutions.

Key Decisions for Investors

• Investors in Honeywell (HON) and Johnson Matthey (JMAT.L) should view this partnership as a positive validation of their technology leadership in the high-growth Sustainable Aviation Fuel market, reinforcing the long-term investment thesis for both firms.
• Given the project is newly announced, it is prudent to monitor for future milestones related to the Bon Wier plant's construction and operational launch, as successful execution will be critical to translating this win into material revenue.
• This partnership is indicative of a broader trend; investors should assess other companies positioned to benefit from the expansion of the bio-refinery and SAF value chain, from feedstock suppliers to competing technology licensors.